Research.Patient.info

Relapsed/refractory multiple myeloma, Amyloid light-chain amyloidosis research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A study to investigate safety and efficacy with SAR445514 in participants with relapsed/refractory multiple myeloma (RRMM) and relapsed/refractory light-chain amyloidosis (RRLCA)
This study is testing a new medicine called SAR445514 for people with multiple myeloma or light-chain amyloidosis that has come back or not responded to past treatments. It's an early-stage study looking at how safe the medicine is and if it works.
Hungary · Belgium · Spain